Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom P Freeman

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
Addiction (Abingdon, England)|January 11, 2025
Commentary on Borodovsky et al.: Enhancing research on THC quantification-Consumer awareness through accurate labellingRachel Lees Thorne, Tom P Freeman
Addiction (Abingdon, England)|May 8, 2018
Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perceptionTom P Freeman, Jack Wilson, Clare Mackie
BMJ (Clinical Research Ed.)|October 23, 2019
Strengthening the evidence for medicinal cannabis and cannabinoidsTom P Freeman, Celia Morgan, Chandni Hindocha
The International Journal on Drug Policy|April 3, 2025
Standard THC units: A tool to benchmark cannabis-related driving risksValentina Lorenzetti, Tom P Freeman, Amie Hayley
The Lancet. Psychiatry|September 12, 2015
Rethinking dose-response effects of cannabis use in adolescenceTom P Freeman, Claire Mokrysz, H Valerie Curran
Addiction (Abingdon, England)|April 16, 2026
Reply to Manthey et al.: Estimating the association between THC and health outcomes requires rigorous research methods and continued monitoring of cannabis marketsRachel Lees Thorne, Will Lawn, Tom P Freeman
The International Journal on Drug Policy|October 29, 2025
Defining a threshold for higher potency cannabis products in legal marketsTom P Freeman, Rachel Lees Thorne, Elle Wadsworth
The Lancet. Child & Adolescent Health|December 22, 2018
Effects of increasing cannabis potency on adolescent healthJack Wilson, Tom P Freeman, Clare J Mackie
Addiction (Abingdon, England)|May 5, 2016
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis useMichael T Lynskey, Chandni Hindocha, Tom P Freeman
Cannabis and Cannabinoid Research|October 31, 2017
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute AdministrationChandni Hindocha, Tom P Freeman, H Valerie Curran
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Addiction (Abingdon, England)|January 11, 2025
Commentary on Borodovsky et al.: Enhancing research on THC quantification-Consumer awareness through accurate labellingRachel Lees Thorne, Tom P Freeman
Addiction (Abingdon, England)|May 8, 2018
Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perceptionTom P Freeman, Jack Wilson, Clare Mackie
BMJ (Clinical Research Ed.)|October 23, 2019
Strengthening the evidence for medicinal cannabis and cannabinoidsTom P Freeman, Celia Morgan, Chandni Hindocha
The International Journal on Drug Policy|April 3, 2025
Standard THC units: A tool to benchmark cannabis-related driving risksValentina Lorenzetti, Tom P Freeman, Amie Hayley
The Lancet. Psychiatry|September 12, 2015
Rethinking dose-response effects of cannabis use in adolescenceTom P Freeman, Claire Mokrysz, H Valerie Curran
Addiction (Abingdon, England)|April 16, 2026
Reply to Manthey et al.: Estimating the association between THC and health outcomes requires rigorous research methods and continued monitoring of cannabis marketsRachel Lees Thorne, Will Lawn, Tom P Freeman
The International Journal on Drug Policy|October 29, 2025
Defining a threshold for higher potency cannabis products in legal marketsTom P Freeman, Rachel Lees Thorne, Elle Wadsworth
The Lancet. Child & Adolescent Health|December 22, 2018
Effects of increasing cannabis potency on adolescent healthJack Wilson, Tom P Freeman, Clare J Mackie
Addiction (Abingdon, England)|May 5, 2016
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis useMichael T Lynskey, Chandni Hindocha, Tom P Freeman
Cannabis and Cannabinoid Research|October 31, 2017
Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute AdministrationChandni Hindocha, Tom P Freeman, H Valerie Curran
Pageof 20